Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

66.7%

2 terminated/withdrawn out of 3 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04128514Terminated

Spectacle Independence and Overall Satisfaction With AcrySof® Panoptix® Toric Intraocular Lens

Role: lead

NCT03326869Not ApplicableTerminated

A Study Raindrop Near Vision Inlay in Presbyopes Implanted in Corneal Pockets

Role: lead

NCT02819908Phase 4Completed

Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery

Role: lead

All 3 trials loaded